Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01
Published November 30, 2016 · Recall initiated: November 4, 2016
Summary
FDA records drug Class III recall D-0147-2017, published November 30, 2016 and initiated November 4, 2016. Recalling firm: West-Ward Pharmaceuticals Corp.; Status: Terminated; Reported quantity: 32,102 bottles; Lot: Lot #: AS1466A, Exp. Jan 2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.
What to do
Voluntary: Firm initiated · Letter
Get an email if AMOXICILLIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMOXICILLIN
- Manufacturer
- West-Ward Pharmaceuticals Corp.
- Distributor
- Nationwide
- UPC
- 0301439887508
- Lot
- Lot #: AS1466A, Exp. Jan 2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVAJanuary 3, 2024
- FDAAMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton,January 3, 2024
- FDAAmoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01June 15, 2022
- FDALactulose Solution, USP, 10 g/15 mL, 15 mL unit dose cups (NDC 66689-039-01), packaged in 15 mL x 50 unit doseNovember 30, 2016
- FDAKENALOG (Triamcinolone Acetonide) Spray with Spray Tube Topical Aerosol, USP, (0.147 mg/g), 15 g bottle,November 30, 2016
- FDAAmoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: TevaAugust 31, 2016
Questions about this recall
Was Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01 recalled?
Yes. FDA published recall D-0147-2017 on November 30, 2016. Reported hazard: Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMOXICILLIN. UPC: 0301439887508.